Skip to main content
Equibles
ECL logo

ECL · Ecolab Inc.

Track ECL — free

Use ECL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ECL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$315.01 +10.33 (+3.39%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$85.45B
Shares
280.47M
Volume · Nov 4 2.74M Avg daily vol (3M) 1.38M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$315.01 Open$311.00 Day$305.82–315.58 52W close$245.73–315.01 Avg vol 30d1.4M Short int4.9M · 1.7% of shares · 4.1d Short vol62% Last earningsOct 27, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 29

Up next

Next earnings call
Jan 26, 2027 Est · unconfirmed · in 12 wks
Q3 2026 earnings call transcript
call held Oct 27, 2026
Play latest call

Latest documents

2026
Oct 29
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Ecolab reported third quarter 2026 net sales of $4,694.8 million, up 13%, and adjusted diluted EPS of $2.18, up 5%; Global Life Sciences organic sales grew 17% to $215.8 million.

Revenue $4.69B ▲ 12.7% Net income $551.3M ▼ 5.8% Diluted EPS $1.95 ▼ 4.9%
Read from the MD&A section
Oct 27
Earnings call
Q3 2026 earnings call

Ecolab reported third quarter 2026 organic sales growth of 7% and organic OI margin of 19.6%. Its 2027 targets include 5-7% organic sales growth, a 20% adjusted operating income margin and adjusted EPS growth of up to 15%.

Read from the first part of this long document
Oct 27
Current report 8-K
Financial results

Ecolab reported third-quarter results for the quarter ended September 30, 2026, including 13% sales growth, 7% organic sales growth, $2.18 adjusted diluted EPS, +5%, and a 19.6% organic operating income margin. It expects 2026 adjusted diluted EPS of $8.10 to $8.20, +8% to 9%.

Read from the first part of this long document
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $4.42B ▲ 9.7% Net income $534.9M ▲ 2.0% Diluted EPS $1.90 ▲ 3.3%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$17.37B
Trailing 12 months
Net income (TTM)
$2.08B
Trailing 12 months
Revenue growth YoY
+12.7%
Year over year
Operating margin
16.7%
Trailing 12 months
P / E (TTM)
41.5
Trailing earnings · reciprocal yield 2.4%
FCF yield
2.1%
TTM · current market cap
Return on invested capital
10.2%
Trailing 12 months
Net cash
−$12.46B
Latest balance sheet
Dividend yield
1.0%
Trailing 12 months
Shares change YoY
-1.2%
Year over year · fewer shares
Price change (1Y)
+18.3%
Trailing year
Short interest
1.7%
Latest settlement · 4.1 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▲1.7% $4.01B $472.90M '24 Q4* ▼1.5% $3.69B $402.50M '25 Q1 ▲1% $4.03B $524.20M '25 Q2 ▲4.2% $4.17B $585.00M '25 Q3 ▲4.8% $4.20B $563.90M '25 Q4* ▲10% $4.07B $432.60M '26 Q1 ▲9.7% $4.42B $534.90M '26 Q2 LATEST ▲12.7% $4.69B $551.30M '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

AI Brief

Q2 FY26 earnings call · Jul 28, 2026
Q2 FY26

TL;DR. Ecolab delivered accelerated 5% organic sales growth and 11% adjusted EPS growth in Q2 2026, raising full-year adjusted EPS guidance to $8.05-$8.25 (from $8.03-$8.23), driven by accelerating growth in Global High-Tech (29%) and Life Sciences (15%) and the recent close of the CoolIT acquisition, while rising commodity costs and Middle East disruption remained headwinds.

Bullish
  • + Raised full-year 2026 adjusted EPS outlook to $8.05-$8.25 from $8.03-$8.23 new
Bearish
  • − Middle East conflict created a ~1% volume headwind in Q2 and is expected to persist new
  • − Reported Q2 GAAP operating income margin fell 40 bps to 17.2% due to amortization and special charges new
  • − Reported GAAP diluted EPS growth slowed to just 3% versus prior year due to special charges new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Weak Quant / Vol Low
Market backdrop VIX 20.8 · elevated Equity put/call 0.60
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +14%
above
Price vs 50-day avg +11%
above
RSI (14) 76
overbought
MACD trend Positive
52-week position 100%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +13%
trailing
6-month return +27%
trailing
YTD return +20%
this year
Relative strength +24%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $283 › 200d $276 — 50d above 200d
Institutional flow Accumulating
812 of 1,723 funds reported for Sep 30 · net +890.4K sh shares · +51 new
Insider flow Distributing
Net -$5.3M over 90 days · 67% sells
Short interest Falling
1.73% of shares out · ▼ -9.6% MoM · 4.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,723 holders — near 3-yr high, broad support
Squeeze score 55
elevated · 0–100
Fundamentals
Weak
Revenue growth +2%
Y/Y
EPS growth −1%
Y/Y
Free cash flow $1.9B
Valuation P/E 41.5
in line
Balance sheet $7.5B
net debt
Quant / Vol
risk profile
Low
Volatility 22%
annualized · 1-yr
Max drawdown −20%
past year
ATR 2.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jul 28, 2026
second half
Organic sales growth Non-GAAP 6% – 7%
Adjusted operating income margin Non-GAAP 19%
Pricing 5% – 6%
the next couple of years
CapEx 7%
not specified
Targeted trajectory (top line growth, Pest Elimination) 6% – 8%
Previous outlook earlier release · from the Earnings Call filed Apr 28, 2026

Still-open targets the latest release did not restate under the same label.

Reported sales growth · 2026 7% – 9%
OI growth · 2026 14% – 16%
EPS growth · 2026 12% – 15%
One Ecolab savings target · by 2027 $325M
OI margin · over 2027 20%
CapEx · 2026 7%
Prior guidance period ended · from the 8-K filed Jul 28, 2026
Adjusted diluted EPS · 3Q 2026 $2.13 – $2.23

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+14% Bullish
Price vs 50-day avg
+11% Bullish
RSI (14)
76 Bearish
MACD trend
Positive Bullish
52-week position
100% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $283 › 200d $276 — 50d above 200d
Institutional flow Accumulating
812 of 1,723 funds reported for Sep 30 · net +890.4K sh shares · +51 new
Insider flow Distributing
Net -$5.3M over 90 days · 67% sells
Short interest Falling
1.73% of shares out · ▼ -9.6% MoM · 4.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,723 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $246 Now $315 · 100% Range high $315
vs 200-day avg +14% vs 50-day avg +11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Non-GAAP adjusted diluted EPS non-GAAP $2.09 the second quarter ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Reported GAAP diluted EPS $1.9
+$0.18 Special (gains) and charges, after tax
+$0.01 Discrete tax expense (benefit)
= Non-GAAP adjusted diluted EPS $2.09
Non-GAAP adjusted fixed currency operating income non-GAAP $808.7M the second quarter ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Non-GAAP adjusted operating income 809M
-0.3M Effect of foreign currency translation
= Non-GAAP adjusted fixed currency operating income 808.7M
Non-GAAP adjusted net income attributable to Ecolab non-GAAP $589.6M the second quarter ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Reported GAAP net income attributable to Ecolab 534.9M
+50.5M Special (gains) and charges, after tax
+4.2M Discrete tax expense (benefit)
= Non-GAAP adjusted net income attributable to Ecolab 589.6M
Non-GAAP adjusted operating income non-GAAP $809M Second Quarter Ended June 30 filing —
GAAP → non-GAAP reconciliation
GAAP Reported GAAP operating income 757.9M
+51.1M Special (gains) and charges
= Non-GAAP adjusted operating income 809M
Non-GAAP adjusted operating income margin non-GAAP 18.3% Second Quarter Ended June 30 filing —
Non-GAAP adjusted tax rate non-GAAP 21% Second Quarter Ended June 30 filing —
GAAP → non-GAAP reconciliation
GAAP Reported GAAP tax rate 22.3%
-0.7% Special (gains) and charges
-0.6% Discrete tax items
= Non-GAAP adjusted tax rate 21%
Non-GAAP organic operating income non-GAAP $804.3M Second Quarter Ended June 30 filing —
GAAP → non-GAAP reconciliation
GAAP Non-GAAP adjusted fixed currency operating income 808.7M
-4.4M Effect of acquisitions and divestitures
= Non-GAAP organic operating income 804.3M
Non-GAAP organic operating income margin non-GAAP 18.8% Second Quarter Ended June 30 filing —
Non-GAAP organic sales non-GAAP $4.28B Second Quarter Ended June 30 filing —
GAAP → non-GAAP reconciliation
GAAP Non-GAAP fixed currency sales 4.4B
-122.3M Effect of acquisitions and divestitures
= Non-GAAP organic sales 4.28B

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ECL
Ecolab Inc.
this stock
$85.45B +20.0% +2.2% 41.5 1.7%
LIN
Linde PLC
 $234.84B +23.1% +3.0% 33.9 1.3%
AIQUF
L Air Liquide SA
 $122.69B +9.1% — — 0.0%
SHW
Sherwin Williams Co
 $87.99B +12.2% +2.1% 33.5 2.7%
APD
Air Products & Chemicals, Inc.
 $69.69B +29.1% -0.5% — 2.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1,740
% held
81.1%
Reported
812 of 1,723
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
883
View
Short & Settlement
Short Interest Falling
Shares short
4.9M
Days to cover
4.1d
Change
-517.8K sh
View
Short Volume
Short vol %
62%
As of
Nov 4, 2026
Short Total
View
Fails to Deliver
FTD shares
12
Value
$3.4K
As of
Sep 28, 2026
View
Off-Exchange
Off-exchange %
40.9%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$5.3M
Buyers / Sellers
1 / 2
Buyers Sellers
View
Congressional Trades Sell
Member
John Boozman
Amount
$1.0K–$15.0K
Traded
May 15, 2026
View
Financials
Financials
Revenue (FY)
$16.1B
Net income (FY)
$2.1B
EPS diluted
$7.28
View
Buybacks
Authorized
shares 10.0M
Remaining
shares 3.5M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 29, 2026
This year
21

Ecolab reported third quarter 2026 net sales of $4,694.8 million, up 13%, and adjusted diluted EPS of $2.18, up 5%; Global Life Sciences organic sales grew 17% to $215.8 million.

View
Proposed Sales
Value
$2.6M
Shares
10.0K
Filed
Jun 9, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 17, 2026
Last webcast
Oct 27, 2026
View
Investor Relations
Latest news
Ecolab Delivers Strong and Accele…
Published
Oct 27, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
ECL +7.7% +13.3% +26.6% +4.0% +20.0%
SPY -0.7% -1.3% +2.5% +1.5% +12.5%
vs SPY +8.4% +14.6% +24.1% +2.5% +7.5%

Capital returns

Latest dividend
$0.73 / share · ex Sep 15, 2026
Raised 12.3%
Paid (TTM)
$2.92 / share · 4 payouts
Dividend yield (TTM, derived)
0.93%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
shares 10.00M
Spent (derived)
shares 6.55M
Remaining
shares 3.45M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 31462 CUSIP 278865100 13F (30d) 802 filings 767 filers Visit website Investor relations